Cerebral Therapeutics Revenue and Competitors

Denver, CO USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Cerebral Therapeutics's estimated annual revenue is currently $4.8M per year.(i)
  • Cerebral Therapeutics's estimated revenue per employee is $201,000

Employee Data

  • Cerebral Therapeutics has 24 Employees.(i)
  • Cerebral Therapeutics grew their employee count by -20% last year.

Cerebral Therapeutics's People

NameTitleEmail/Phone
1
VP Clinical Development Reveal Email/Phone
2
Sr Director, Pharmaceutical DevelopmentReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
DirectorReveal Email/Phone
5
Chief Financial OfficerReveal Email/Phone
6
Senior Director Quality and Device DevelopmentReveal Email/Phone
7
Chief Operating OfficerReveal Email/Phone
8
Senior Product Development Project ManagerReveal Email/Phone
9
Principal Systems EngineerReveal Email/Phone
10
President, Cerebral Therapeutics, Inc.Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M250%N/AN/A
#2
$10.3M516%N/AN/A
#3
$4.4M22-8%N/AN/A
#4
$195M1220%$121.4MN/A
#5
$4.8M24-20%N/AN/A
#6
$6.8M34-19%N/AN/A
#7
$4.8M240%N/AN/A
#8
$4M40-11%$138MN/A
#9
$4.8M24-14%N/AN/A
#10
$69.5M346-6%N/AN/A
Add Company

What Is Cerebral Therapeutics?

Cerebral Therapeutics, Inc. is a clinical-stage pharmaceutical company dedicated to improving the lives of patients living with severe refractory epilepsy and other uncontrolled neurological diseases. Founded by experts in the fields of neurology, neurosurgery, and drug delivery, the Company is pioneering the development of drug-device combination therapies that enable precise targeted delivery to the central nervous system.

keywords:N/A

N/A

Total Funding

24

Number of Employees

$4.8M

Revenue (est)

-20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cerebral Therapeutics News

2022-04-20 - Ischemic Cerebral Stroke Prevention Therapeutics Market Size ...

Ischemic Cerebral Stroke Prevention Therapeutics Market Size, Outlook And Forecast | Johnson & Johnson, Boston Therapeutics, Edge Therapeutics, Zocere, Lundbeck...

2022-04-20 - Cerebral Malaria Therapeutics Market Size, Outlook And Forecast ...

Cerebral Malaria Therapeutics Market Size, Outlook And Forecast | Novartis, Cipla, Zydus Cadila, Ipca Laboratories, Sanofi, Eisai. Photo of...

2022-03-22 - Argenica Therapeutics records positive results from ARG-007 study ...

Argenica Therapeutics ASX AGN positive results ARG-007 study cerebral ischaemia Argenica chief executive officer Dr Liz Dallimore says the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A240%N/A
#2
$5.1M24-4%N/A
#3
$5.5M249%N/A
#4
$4.2M24-45%N/A
#5
$3M244%N/A